{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:48:14Z","timestamp":1785754094068,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13595-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:15:54Z","timestamp":1780071354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with the costs of treating privately insured adults with complicated urinary tract infections"],"prefix":"10.1186","volume":"26","author":[{"given":"Kenneth","family":"Thorpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Joski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"10","key":"13595_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586\u2013600. https:\/\/doi.org\/10.1038\/s41585-020-0362-4 . Epub 2020 Aug 25. PMID: 32843751.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"13595_CR2","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1017\/ash.2025.10045","volume":"5","author":"SD Advani","year":"2025","unstructured":"Advani SD, Luck ME, Chang R, et al. Assessing the burden of outpatient urinary tract infections in the United States: analysis of nationwide ambulatory data (2016\u20132019). Antimicrob Steward Healthc Epidemiol. 2025;5(1):e143. https:\/\/doi.org\/10.1017\/ash.2025.10045. Published 2025 Jun 30.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"5","key":"13595_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"key":"13595_CR4","doi-asserted-by":"publisher","unstructured":"Nicolle LE. Urinary tract infection. Crit Care Clin. 2013;29(3):699\u2013715. https:\/\/doi.org\/10.1016\/j.ccc.2013.03.014. PMID: 23830659.","DOI":"10.1016\/j.ccc.2013.03.014"},{"key":"13595_CR5","unstructured":"Sabih A, Leslie SW. Complicated urinary tract infections. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK436013\/."},{"key":"13595_CR6","doi-asserted-by":"publisher","unstructured":"Zilberberg M, Nathanson B, Sulham K, et al. Descriptive epidemiology and outcomes of hospitalizations with complicated urinary tract infections in the United States, 2018. Open Forum Infect Dis. 2022;9(1):591. https:\/\/doi.org\/10.1093\/ofid\/ofab591","DOI":"10.1093\/ofid\/ofab591"},{"issue":"11","key":"13595_CR7","doi-asserted-by":"publisher","first-page":"ofz446","DOI":"10.1093\/ofid\/ofz446","volume":"6","author":"JJ Carreno","year":"2019","unstructured":"Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP Jr. Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2019;6(11):ofz446. https:\/\/doi.org\/10.1093\/ofid\/ofz446.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"13595_CR8","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ajic.2021.05.013","volume":"49","author":"TP Lodise","year":"2021","unstructured":"Lodise TP, Chopra T, Nathanson BH, Sulham K. Hospital admission patterns of adult patients with complicated urinary tract infections who present to the hospital by disease acuity and comorbid conditions: How many admissions are potentially avoidable? Am J Infect Control. 2021;49(12):1528\u201334. Epub 2021 May 30. PMID: 34077786.","journal-title":"Am J Infect Control"},{"issue":"7","key":"13595_CR9","doi-asserted-by":"publisher","first-page":"ofac307","DOI":"10.1093\/ofid\/ofac307","volume":"9","author":"TP Lodise","year":"2022","unstructured":"Lodise TP, Manjelievskaia J, Marchlewicz EH, Rodriguez M. Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections. Open Forum Infect Dis. 2022;9(7):ofac307. https:\/\/doi.org\/10.1093\/ofid\/ofac307 . PMID: 35891695; PMCID: PMC9308450.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"13595_CR10","doi-asserted-by":"publisher","first-page":"ofab591","DOI":"10.1093\/ofid\/ofab591","volume":"9","author":"MD Zilberberg","year":"2022","unstructured":"Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018. Open Forum Infect Dis. 2022;9(1):ofab591. https:\/\/doi.org\/10.1093\/ofid\/ofab591 . PMID: 35036460; PMCID: PMC8754377.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"13595_CR11","doi-asserted-by":"publisher","first-page":"ofw281","DOI":"10.1093\/ofid\/ofw281","volume":"4","author":"JE Simmering","year":"2017","unstructured":"Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998\u20132011. Open Forum Infect Dis. 2017;4(1):ofw281. https:\/\/doi.org\/10.1093\/ofid\/ofw281 . PMID: 28480273; PMCID: PMC5414046.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"13595_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ajem.2009.03.003","volume":"28","author":"JW Schrock","year":"2010","unstructured":"Schrock JW, Reznikova S, Weller S. The effect of an observation unit on the rate of ED admission and discharge for pyelonephritis. Am J Emerg Med. 2010;28(6):682\u20138. https:\/\/doi.org\/10.1016\/j.ajem.2009.03.003.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"13595_CR13","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1038\/s41598-021-86246-7","volume":"11","author":"T Babich","year":"2021","unstructured":"Babich T, Eliakim-Raz N, Turjeman A, Pujol M, Carratal\u00e0 J, Shaw E, Gomila Grange A, Vuong C, Addy I, Wiegand I, Grier S, MacGowan A, van den Vank C, Leibovici L. Risk factors for hospital readmission following complicated urinary tract infection. Sci Rep. 2021;11(1):6926. https:\/\/doi.org\/10.1038\/s41598-021-86246-7 . PMID: 33767321; PMCID: PMC7994309.","journal-title":"Sci Rep"},{"key":"13595_CR14","doi-asserted-by":"publisher","first-page":"e020251","DOI":"10.1136\/bmjopen-2017-020251","volume":"8","author":"L Vallejo-Torres","year":"2018","unstructured":"Vallejo-Torres L, Pujol M, Shaw E, et al. Cost of hospitalized patients due to a complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET RESCUING study. BMJ Open. 2018;8:e020251. https:\/\/doi.org\/10.1136\/bmjopen-2017-020251.","journal-title":"BMJ Open"},{"key":"13595_CR15","doi-asserted-by":"crossref","unstructured":"Trautner BW, Cort\u00e9s-Penfield NW, Gupta K, et al. 2025 clinical practice guideline by the Infectious Diseases Society of America (IDSA): management and treatment of complicated urinary tract infections. Clin Infect Dis. 2025 Jul 17.","DOI":"10.1093\/cid\/ciaf459"},{"key":"13595_CR16","unstructured":"Merative MarketScan Research Databases. 2019\u20132022. Merative US L.P. (formerly IBM Watson Health). De-identified longitudinal patient-level claims data from commercial and Medicare supplemental insurance plans in the United States."},{"key":"13595_CR17","volume-title":"Medical Episode Grouper (MEG): User Guide","author":"Thomson Medstat","year":"2007","unstructured":"Thomson Medstat. Medical Episode Grouper (MEG): User Guide. Ann Arbor, MI: Thomson Healthcare; 2007."},{"issue":"4","key":"13595_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0167-6296(01)00086-8","volume":"20","author":"WG Manning","year":"2001","unstructured":"Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ. 2001;20(4):461\u201394. https:\/\/doi.org\/10.1016\/S0167-6296(01)00086-8.","journal-title":"J Health Econ"},{"key":"13595_CR19","doi-asserted-by":"publisher","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8 . PMID: 3558716.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"13595_CR20","doi-asserted-by":"crossref","unstructured":"Medina M, Castillo-Pino E. Therapeutic advances in urology. Ther Adv Urol. 2019;11.","DOI":"10.1177\/1756287219832172"},{"issue":"2","key":"13595_CR21","doi-asserted-by":"publisher","first-page":"117181","DOI":"10.1016\/j.diagmicrobio.2025.117181","volume":"114","author":"JD Kittle Jr","year":"2026","unstructured":"Kittle JD Jr, Lwande JS, Jangir MM, Zupancic T, Brody RS, Hecker M, DiFranco-Fisher JM, Kargiotis C, Koeth LM. A rapid bacterial labeling method for phenotypic antimicrobial susceptibility testing. Diagn Microbiol Infect Dis. 2026;114(2):117181.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13595-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:26:20Z","timestamp":1785752780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13595-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13595"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13595-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study used secondary de-identified data from the Merative-MarketScan database and was determined to be not human subjects research as defined by Emory University Institutional Review Board and therefore was waived by the Emory University Institutional Review Board from formal ethics approval. Due to the retrospective de-identified data used and nature of the study the requirement for informed consent was waived by the Emory University Institutional Review Board. All methods were carried out in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1418"}}